The prognostic value of first-trimester cystatin C levels for gestational complications

References

[1] Henskens YMC, Veerman ECI, Amerongen AVN. Cystatins in health and diseases. Biol Chem Hoppe-Seyler. 1996;377:71–86.Search in Google Scholar

[2] Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998;93:1135–45.10.1016/S0092-8674(00)81458-0Search in Google Scholar

[3] Grubb AO. Cystatin C, properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63–99.10.1016/S0065-2423(01)35015-1Search in Google Scholar

[4] Kristensen K, Lindström V, Schmidt C, Blirup-Jensen S, Grubb A, Wide-Swensson D, et al. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest. 2007;67:612–8.10.1080/00365510701203488Search in Google Scholar

[5] Salgado JV, Souza FL, Salgado BJ. How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence? J Cardiol. 2013;62:331–5.10.1016/j.jjcc.2013.05.015Search in Google Scholar

[6] Liu P, Sui SJ, Xu DL, Xing XW, Liu CX. Association of cystatin C and metabolic syndrome. Zhonghua Yi Xue Za Zhi. 2013;29:93:3207–10.Search in Google Scholar

[7] Spong CY. Defining “term” pregnancy: recommendations from the Defining “Term” Pregnancy Workgroup. J Am Med Assoc. 2013;309:2445–6.10.1001/jama.2013.6235Search in Google Scholar

[8] Practice bulletins No. 139: premature rupture of membranes. Obstet Gynecol. 2013;122:918–30.10.1097/01.AOG.0000435415.21944.8fSearch in Google Scholar

[9] Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30:2:251–60.10.2337/dc07-s225Search in Google Scholar

[10] American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122.Search in Google Scholar

[11] Phelan JP, Ahn MO, Smith CV, Rutherford SE, Anderson E. Amniotic fluid index measurements during pregnancy. J Reprod Med. 1987;32:601–4.Search in Google Scholar

[12] Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967;71:159.10.1016/S0022-3476(67)80066-0Search in Google Scholar

[13] Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A New equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.10.7326/0003-4819-150-9-200905050-00006Search in Google Scholar PubMed PubMed Central

[14] Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.10.1056/NEJMoa1114248Search in Google Scholar PubMed PubMed Central

[15] Arimoto TT, Yasuchika N, Takeshi T, Noriaki O, Hidenobu F, Akio T, et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail. 2005;11:595–601.10.1016/j.cardfail.2005.06.001Search in Google Scholar PubMed

[16] Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, et al. Cystatin Cconcentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497–505.10.7326/0003-4819-142-7-200504050-00008Search in Google Scholar PubMed

[17] Urbonaviciene G, Shi GP, Urbonavicius S, Henneberg EW, Lindholt JS. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis. 2011;216:440–5.10.1016/j.atherosclerosis.2011.02.016Search in Google Scholar PubMed PubMed Central

[18] Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;15;345:760–5.10.1126/science.1251816Search in Google Scholar PubMed PubMed Central

[19] Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007;21:467–78.10.1016/j.bpobgyn.2007.01.008Search in Google Scholar PubMed

[20] Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. Placenta. 2006;27:1037–51.10.1016/j.placenta.2006.01.002Search in Google Scholar PubMed

[21] Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie. 2010;92:1580–6.10.1016/j.biochi.2010.04.011Search in Google Scholar PubMed

[22] Smith ER. Cystatin C – more than a filtration marker? Atherosclerosis. 2013;230:73–5.10.1016/j.atherosclerosis.2013.06.023Search in Google Scholar PubMed

[23] Xie L, Terrand J, Xu B, Tsaprailis G, Boyer J, Chen QM. Cystatin C increases in cardiac injury: role in extracellular matrix protein modulation. Cardiovasc Res. 2010;87:628–35.10.1093/cvr/cvq138Search in Google Scholar PubMed PubMed Central

[24] Thilaganathan B, Ralph E, Papageorghiou AT, Melchiorre K, Sheldon J. Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia. Reprod Sci. 2009;16:788–93.10.1177/1933719109336618Search in Google Scholar PubMed

[25] Malak TM, Ockleford CD, Bell SC, Dalgleish R, Bright N, Macvicar J. Confocal immuno-fluorescence localization of collagen types I, III, IV, VI and their ultrastructural organization in term human fetal membranes. Placenta. 1993;14:385–406.10.1016/S0143-4004(05)80460-6Search in Google Scholar

[26] Phaloprakarn C, Manusirivithaya S, Boonyarittipong P. Risk score comprising maternal and obstetric factors to identify late preterm infants at risk for neonatal intensive care unit admission. J Obstet Gynaecol Res. 2014;41:680–8.10.1111/jog.12610Search in Google Scholar PubMed

[27] Obrenovic R, Petrovic D, Majkic-Singh N, Trbojevic-Stankovic J, Stojimirovic B. Serum cystatin C levels in normal pregnancy. Clin Nephrol. 2011;76:174–9.10.5414/CN106792Search in Google Scholar

[28] Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG. 2008;115:874–81.10.1111/j.1471-0528.2008.01709.xSearch in Google Scholar PubMed

[29] Strevens H, Wide Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62:141–7.10.1080/003655102753611771Search in Google Scholar PubMed

[30] Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand. 2009;88:479–82.10.1080/00016340902777517Search in Google Scholar PubMed